Ozen, B. Et Al. 2024. Favipiravir does not appear to be a major teratogen: Case series from Türkiye. JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION , vol.53, no.1 .

Ozen, B., US, Z., Toplu, A., Vizdiklar, C., Selalmaz, Y., Culpan, Y., ... Asik, Z. T.(2024). Favipiravir does not appear to be a major teratogen: Case series from Türkiye. JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION , vol.53, no.1.

Ozen, Berna Et Al. "Favipiravir does not appear to be a major teratogen: Case series from Türkiye," JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION , vol.53, no.1, 2024

Ozen, Berna Et Al. "Favipiravir does not appear to be a major teratogen: Case series from Türkiye." JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION , vol.53, no.1, 2024

Ozen, B. Et Al. (2024) . "Favipiravir does not appear to be a major teratogen: Case series from Türkiye." JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION , vol.53, no.1.

@article{article, author={Berna Ozen Et Al. }, title={Favipiravir does not appear to be a major teratogen: Case series from Türkiye}, journal={JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION}, year=2024}